Suberohydroxamic acid
![]() |
- ₹5130 - ₹15469.99
- Product name: Suberohydroxamic acid
- CAS: 38937-66-5
- MF: C8H16N2O4
- MW: 204.22
- EINECS:
- MDL Number:MFCD00192455
- Synonyms:ODHA;OCTANE-1,8-DIHYDROXAMIC ACID;SBHA;SUBERIC BISHYDROXAMATE;SUBEROHYDROXAMIC ACID;SUBEROYL BISHYDROXAMIC ACID;STAT3 (PTYR705);[PTYR705]-STAT3
2 prices
Selected condition:
Brand
- Sigma-Aldrich(India)
Package
- 100MG
- 1G
- ManufacturerSigma-Aldrich(India)
- Product number390585
- Product descriptionSuberohydroxamic acid 95%
- Packaging1G
- Price₹5130
- Updated2022-06-14
- Buy
- ManufacturerSigma-Aldrich(India)
- Product number559418
- Product descriptionSBHA - CAS 38937-66-5 - Calbiochem A cell-permeable bishydroxamic acid histone deacetylase (HDAC) inhibitor with anti-tumor properties.
- Packaging100MG
- Price₹15469.99
- Updated2022-06-14
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
Sigma-Aldrich(India) | 390585 | Suberohydroxamic acid 95% | 1G | ₹5130 | 2022-06-14 | Buy |
Sigma-Aldrich(India) | 559418 | SBHA - CAS 38937-66-5 - Calbiochem A cell-permeable bishydroxamic acid histone deacetylase (HDAC) inhibitor with anti-tumor properties. | 100MG | ₹15469.99 | 2022-06-14 | Buy |
Properties
Melting point :153-155 °C(lit.)
Density :1.219±0.06 g/cm3(Predicted)
storage temp. :−20°C
solubility :H2O: soluble
pka :9.18±0.20(Predicted)
form :lyophilized powder
color :White to Light Beige
Stability :Hygroscopic
Density :1.219±0.06 g/cm3(Predicted)
storage temp. :−20°C
solubility :H2O: soluble
pka :9.18±0.20(Predicted)
form :lyophilized powder
color :White to Light Beige
Stability :Hygroscopic
Safety Information
Symbol(GHS): | ||||||||
---|---|---|---|---|---|---|---|---|
Signal word: | ||||||||
Hazard statements: |
|
|||||||
Precautionary statements: |
|
Description
Suberohydroxamic acid (SBHA) is a competitive histone deacetylase (HDAC) inhibitor that has been shown to inhibit HDAC1 (IC50 = 0.25 μM) and HDAC3 (IC50 = 0.30 μM). SBHA causes cell differentiation, cell cycle arrest, or apoptosis. HDAC inhibitors, including SBHA, act synergistically to kill cancer cells when used in combination with cytostatic drugs, allowing lower doses of both inhibitors and drugs to be used.More related product prices
Salicylhydroxamic acid Parthenolide M344 HC TOXIN Entinostat Tubacin OXAMFLATIN CAY10603 APICIDIN 200626-61-5 Sodium 4-phenylbutyrate SPLITOMICIN SCRIPTAIDRelated product price
- Salicylhydroxamic acid
₹1634.58-5607.35 - Parthenolide
₹3900-21195.35 - M344
₹5600-77885.88